May 15, 2019 (Noon–1 p.m. ET)
Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act, NICHD
For this webinar, Donna L. Snyder, M.D., will cover the foundations and mandatory and optional elements of informed consent. She also will discuss the obtaining of consent/assent from vulnerable subjects, reasonably foreseeable risks, and the regulations governing informed consent.
Dr. Snyder is a pediatric ethicist and team lead in the Office of Pediatric Therapeutics in the Office of the Commissioner at the U.S. Food and Drug Administration.
George Giacoia, OPPTB, NICHD